2020
DOI: 10.1186/s12931-020-01367-3
|View full text |Cite
|
Sign up to set email alerts
|

Differences in airway microbiome and metabolome of single lung transplant recipients

Abstract: Background: Recent studies suggest that alterations in lung microbiome are associated with occurrence of chronic lung diseases and transplant rejection. To investigate the host-microbiome interactions, we characterized the airway microbiome and metabolome of the allograft (transplanted lung) and native lung of single lung transplant recipients. Methods: BAL was collected from the allograft and native lungs of SLTs and healthy controls. 16S rRNA microbiome analysis was performed on BAL bacterial pellets and sup… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
15
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 67 publications
3
15
0
Order By: Relevance
“…A significant difference among the F/B ratio was observed among the control and high dose group suggesting dysbiosis in the lung microbiome post SARS-CoV-2 infection with a high dose. Similar results were observed in patients that underwent lung transplants but to our knowledge, this has not been thoroughly examined in respiratory viral infections (69).…”
Section: Discussionsupporting
confidence: 80%
“…A significant difference among the F/B ratio was observed among the control and high dose group suggesting dysbiosis in the lung microbiome post SARS-CoV-2 infection with a high dose. Similar results were observed in patients that underwent lung transplants but to our knowledge, this has not been thoroughly examined in respiratory viral infections (69).…”
Section: Discussionsupporting
confidence: 80%
“…A significant difference among the F/B ratios was observed between the control and high-dose groups, suggesting dysbiosis in the lung microbiome post-SARS-CoV-2 infection with a high dose. Similar results were observed in patients that underwent lung transplants, but to our knowledge, this has not been thoroughly examined in respiratory viral infections ( 69 ).…”
Section: Discussionsupporting
confidence: 77%
“…Despite the advances in microbiome research, our knowledge of the airway microbiome is still way behind compared to that of the gut microbiome. And as such, lung microbiota composition, microbiota derived metabolites and how they could contribute to lung inflammation, immunity and disease is only in its infancy [ 239 , 240 ]. Alterations in bacterial burden, gut microbial species and the metabolites they produce are associated with altered inflammation and immunity in the lungs as well as the development of lung diseases.…”
Section: Host Nutrient Availability and The Microbiome Of The Lungmentioning
confidence: 99%